Flying Point Industries

IDBiologics, founded in 2017, focuses on the discovery and development of human monoclonal antibodies aimed at preventing, treating, and curing infectious diseases. Utilizing a proprietary fully human monoclonal antibody platform, the company excels in the rapid discovery and optimization of therapeutic molecules. This innovative approach allows IDBiologics to isolate a diverse range of antibodies specifically targeting various infectious diseases, with several lead candidate molecules advancing through the development process. By prioritizing the creation of effective therapeutic solutions, IDBiologics aims to enhance the capabilities of physicians in combating infectious diseases.

Matchwell LLC operates an online marketplace designed to connect clinicians with healthcare facilities. Founded in 2017 and based in Durham, North Carolina, the platform allows healthcare professionals, including nurses and therapists, to join preferred facility pools and access available shift information. Clinicians can communicate directly with facility hiring managers to discuss opportunities, facilitating a streamlined recruitment process for both parties. By offering options for short-term and long-term contracts, Matchwell aims to meet the diverse employment needs of healthcare professionals while helping facilities fill staffing gaps effectively.

Pops Diabetes Care, Inc. is a company dedicated to developing glucose monitoring devices and a virtual healthcare platform aimed at assisting individuals in self-managing diabetes. Founded in 2010 and headquartered in Stillwater, Minnesota, the company focuses on consumer-centric sensors that have demonstrated effectiveness in reducing glucose levels. This innovative approach not only enhances diabetes management but also provides significant cost savings, with users potentially saving over $2,000 annually. Through its commitment to improving diabetes care, Pops Diabetes Care is positioned to make a meaningful impact in the lives of those living with this chronic condition.

IPwe, Inc. operates an online platform that facilitates the buying and selling of patents while offering a range of patent-related services. Incorporated in 2018 and headquartered in Dallas, Texas, with an additional office in Paris, the company aims to democratize the intellectual property space by creating a transparent marketplace for patent transactions. Utilizing blockchain technology, smart contracts, artificial intelligence, and predictive analytics, IPwe seeks to streamline the patent market, reducing inefficiencies and associated costs. The platform caters to a diverse clientele, including patent owners, service providers, lenders, investors, corporate entities, lawyers, and individuals, enabling traditional transactions such as licensing and acquisitions, as well as innovative activities like patent financing and maintenance fee payments. Through its comprehensive tools and data, IPwe empowers users to better understand and manage their patent portfolios, ultimately enhancing value and fostering innovation.